Abstract
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly pathogenic and contagious coronavirus that caused a global pandemic with 5.2 million fatalities to date. Questions concerning serologic features of long-term immunity, especially dominant epitopes mediating durable antibody responses after SARS-CoV-2 infection, remain to be elucidated.
Objective: We aimed to dissect the kinetics and longevity of immune responses in coronavirus disease 2019 (COVID-19) patients, as well as the epitopes responsible for sustained long-term humoral immunity against SARS-CoV-2.
Methods: We assessed SARS-CoV-2 immune dynamics up to 180 to 220 days after disease onset in 31 individuals who predominantly experienced moderate symptoms of COVID-19, then performed a proteome-wide profiling of dominant epitopes responsible for persistent humoral immune responses.
Results: Longitudinal analysis revealed sustained SARS-CoV-2 spike protein-specific antibodies and neutralizing antibodies in COVID-19 patients, along with activation of cytokine production at early stages after SARS-CoV-2 infection. Highly reactive epitopes that were capable of mediating long-term antibody responses were shown to be located at the spike and ORF1ab proteins. Key epitopes of the SARS-CoV-2 spike protein were mapped to the N-terminal domain of the S1 subunit and the S2 subunit, with varying degrees of sequence homology among endemic human coronaviruses and high sequence identity between the early SARS-CoV-2 (Wuhan-Hu-1) and current circulating variants.
Conclusion: SARS-CoV-2 infection induces persistent humoral immunity in COVID-19-convalescent individuals by targeting dominant epitopes located at the spike and ORF1ab proteins that mediate long-term immune responses. Our findings provide a path to aid rational vaccine design and diagnostic development.
Keywords: COVID-19; SARS-CoV-2; dominant epitope; humoral immunity; long-term immune response; proteome-wide peptide microarray.
【저자키워드】 COVID-19, SARS-CoV-2, Humoral immunity, dominant epitope, long-term immune response, proteome-wide peptide microarray., 【초록키워드】 coronavirus disease, severe acute respiratory syndrome coronavirus 2, neutralizing antibody, Coronavirus disease 2019, coronavirus, immune response, Immunity, Neutralizing antibodies, antibody, SARS-COV-2 infection, Antibody Response, Vaccine design, diagnostic, peptide, cytokine, Proteins, severe acute respiratory syndrome Coronavirus, immune, Spike protein, global pandemic, Protein, Epitopes, Humoral immunity, Kinetics, immune responses, SARS-CoV-2 spike protein, proteome, respiratory, Longevity, epitope, humoral immune responses, longitudinal, moderate, early stage, patients, S2 subunit, cytokine production, COVID-19 patients, dominant epitope, specific antibodies, SARS-CoV-2 spike, N-terminal domain, longitudinal analysis, fatality, S1 subunit, Analysis, ORF1ab, disease onset, humoral, moderate symptoms, acute respiratory syndrome, Activation, acute respiratory syndrome coronavirus, individual, early stages, sequence homology, peptide microarray, symptoms of COVID-19, path, contagious, sequence identity, circulating variants, highly pathogenic, COVID-19-convalescent individuals, endemic human coronaviruses, Wuhan-Hu-1, dominant, feature, long-term immune responses, reactive, shown, responsible, the S1 subunit, performed, caused, induce, dissect, mapped, concerning, sustained, COVID-19-convalescent individual, endemic human coronavirus, the early SARS-CoV-2, the SARS-CoV-2, 【제목키워드】 immune profiling, longitudinal, reveal, COVID-19-convalescent individual,